2022-01-03 | Sale | Editas Medicine, Inc. EDIT | CEO | 18,252 0.026% | $26.95 | $491,979 | -47.34% | |
2021-10-18 | Sale | Editas Medicine, Inc. EDIT | CEO | 13,805 0.0201% | $38.03 | $525,033 | -57.33% | |
2021-03-02 | Editas Medicine, Inc. EDIT | CEO | 25,000 0.0384% | $46.27 | $1.16M | -17.22% | ||
2018-05-18 | Editas Medicine, Inc. EDIT | director | 10,000 0.0232% | $38.03 | $380,252 | -20.34% | ||
2017-11-13 | Insulet Corporation PODD | director | 2,500 0.0042% | $67.45 | $168,633 | +26.04% | ||
2010-03-22 | Sale | Biogen Inc. BIIB | CEO & President | 106,279 0.0395% | $59.95 | $6.37M | -3.61% | |
2010-03-19 | Sale | Biogen Inc. BIIB | CEO & President | 334,221 0.1245% | $59.97 | $20.04M | -3.36% | |
2009-12-16 | Sale | Biogen Inc. BIIB | CEO & President | 147,037 0.0544% | $50.18 | $7.38M | +10.12% | |
2008-04-15 | Sale | Biogen Inc. BIIB | CEO & President | 12,800 0.003% | $44.59 | $570,752 | -22.49% | |
2008-04-14 | Sale | Biogen Inc. BIIB | CEO & President | 200 <0.0001% | $44.59 | $8,918 | -21.01% | |
2008-04-11 | Sale | Biogen Inc. BIIB | CEO & President | 745,750 0.259% | $64.75 | $48.29M | -21.64% | |
2006-11-27 | Sale | Biogen Inc. BIIB | CEO & President | 12,500 0.0026% | $36.09 | $451,125 | +0.96% | |
2006-11-20 | Sale | Biogen Inc. BIIB | CEO & President | 159,000 0.0468% | $51.11 | $8.13M | +0.47% | |
2006-11-17 | Sale | Biogen Inc. BIIB | CEO & President | 70,123 0.0204% | $49.95 | $3.5M | +1.41% | |
2006-11-16 | Sale | Biogen Inc. BIIB | CEO & President | 220,565 0.0592% | $45.40 | $10.01M | +3.1% | |
2006-04-28 | Sale | Biogen Inc. BIIB | CEO & President | 8,675 0.0026% | $45.25 | $392,559 | +1.98% | |
2005-01-24 | Sale | Biogen Inc. BIIB | CEO & President | 5,500 0.0016% | $63.22 | $347,716 | -37.33% | |
2005-01-18 | Sale | Biogen Inc. BIIB | CEO & President | 5,500 0.0016% | $67.78 | $372,770 | -41.77% | |
2005-01-10 | Sale | Biogen Inc. BIIB | CEO & President | 5,500 0.0016% | $66.52 | $365,857 | -40.92% | |
2005-01-03 | Sale | Biogen Inc. BIIB | CEO & President | 5,500 0.0017% | $67.67 | $372,163 | -40.44% |